John M. Desmarais, Director, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 250,000 shares at $4.00 ($1.0M) on 2016-03-18, disclosed to the SEC on 2016-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.